XML 35 R26.htm IDEA: XBRL DOCUMENT

Equity Investments	6 Months Ended
Jun. 30, 2022
Investments All Other Investments [Abstract]
Equity Investment	18. Equity Investments — In February 2016, AMVAC Netherlands BV made an investment in Biological Products for Agriculture (“Bi-PA”). Bi-PA develops biological plant protection products that can be used for the control of pests and disease of agricultural crops. As of June 30, 2022 and 2021, the Company’s ownership position in Bi-PA was 15%. Since this investment does not have readily determinable fair value, the Company has elected to measure the investment at cost less impairment, if any, and also records an increase or decrease for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of Bi-PA. The Company periodically reviews the investment for possible impairment. There was no impairment or observable price changes on the investment during the three- and six-month periods ended June 30, 2022 and 2021. The investment is recorded within other assets on the condensed consolidated balance sheets and amounted to $2,884 as of June 30, 2022 and December 31, 2021. On April 1, 2020, AMVAC purchased 6.25 million shares, an ownership of approximately 8%, of common stock of Clean Seed Capital Group Ltd. (TSX Venture Exchange: “CSX”) for $1,190. The shares are publicly traded, have a readily determinable fair value, and are considered a Level 1 investment. The fair value of the stock amounted to $1,113 and $1,516 as of June 30, 2022 and December 31, 2021, respectively. The Company recorded a loss of $486 and $295 for the three-month period ended June 30, 2022 and 2021, respectively. The Company recorded a loss of $403 and a gain of $771 for the six months ended June 30, 2022 and 2021, respectively The investment is recorded within other assets on the condensed consolidated balance sheets.

Equity Investments

6 Months Ended

Jun. 30, 2022

Investments All Other Investments [Abstract]

18. Equity Investments — In February 2016, AMVAC Netherlands BV made an investment in Biological Products for Agriculture (“Bi-PA”). Bi-PA develops biological plant protection products that can be used for the control of pests and disease of agricultural crops. As of June 30, 2022 and 2021, the Company’s ownership position in Bi-PA was 15%. Since this investment does not have readily determinable fair value, the Company has elected to measure the investment at cost less impairment, if any, and also records an increase or decrease for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of Bi-PA. The Company periodically reviews the investment for possible impairment. There was no impairment or observable price changes on the investment during the three- and six-month periods ended June 30, 2022 and 2021. The investment is recorded within other assets on the condensed consolidated balance sheets and amounted to $2,884 as of June 30, 2022 and December 31, 2021.

On April 1, 2020, AMVAC purchased 6.25 million shares, an ownership of approximately 8%, of common stock of Clean Seed Capital Group Ltd. (TSX Venture Exchange: “CSX”) for $1,190. The shares are publicly traded, have a readily determinable fair value, and are considered a Level 1 investment. The fair value of the stock amounted to $1,113 and $1,516 as of June 30, 2022 and December 31, 2021, respectively. The Company recorded a loss of $486 and $295 for the three-month period ended June 30, 2022 and 2021, respectively. The Company recorded a loss of $403 and a gain of $771 for the six months ended June 30, 2022 and 2021, respectively The investment is recorded within other assets on the condensed consolidated balance sheets.